Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
61 Cards in this Set
- Front
- Back
Motor unit=
|
AHC + all the muscle fibers it innervates.
|
|
|
-xs of normal skeletal m.
-multinucleated; MOST nuclei peripheral |
|
Organization of a sarcomere?
|
|
|
|
sarcomere on EM
|
|
|
|
|
Contrast type 1 and 2 m fibers:
|
Type 1:
Red (dark meat) Slow twitch Sustained action Oxidative enzymes (NADH) More mitochondria More fat Oxidative phosphorylation Type 2: White (meat) Fast twitch Rapid action Glycolytic enzymes (phosphorylase) Fewer mitochondria Less fat Glycolysis |
|
Different composition of muscle in different people
|
|
|
|
ATPase stain of m.
-type 2 fibers are dark -type 1 fibers are light -they are intermixed with each other in normal muscle. |
|
|
A: ATPase histochemical staining, at pH 9.4, of normal muscle showing checkerboard distribution of intermingled type 1 (light) and type 2 (dark) fibers.
B: in contrast, fibers of either histochemical type are grouped together after reinnervation of muscle. This is not normal muscle! C: A cluster of atrophic fibers (group atrophy) in the center (arrow). In neurogenic disease. |
|
Muscle Atrophy:
|
*Nonspecific response to a variety of skeletal muscle disorders, myopathies, and dystrophies
*Abnormally small myofibers *Specific types of atrophy -Neurogenic atrophy -Type 2 fiber atrophy +Corticosteroid myopathy +Disuse myopathy |
|
|
-Early denervation.
-typically involves early type 2 selective atrophy |
|
|
-Individual fiber atrophy (early denervation)
-typically involves early type 2 selective atrophy |
|
|
-Fiber type grouping
-Leading to grouped atrophy |
|
|
Grouped atrophy
|
|
|
-Re-innervation- Type grouping- ATPase
-indicative of some kind of neurogenic disease. |
|
|
-Type 2 Fiber Atrophy
-from chronic steroid use or disuse of muscle. |
|
Dystrophy vs. congenital myopathy:
|
Dystrophy:
A degenerative disorder with destruction of muscles Progressive weakness Develops after birth Congenital Myopathy: A fixed dysfunction of muscle Nonprogressive muscle weakness Present at birth |
|
Duchenne Muscular Dystrophy:
|
*X-linked (boys)
*Onset at age 5-6: children walk but never run *Proximal muscle weakness *Pseudohypertrophy of calves *Greatly elevated creatine phosphokinase (CPK) *Wheelchair-bound in early teens *Death in late teens |
|
inheritance vs. de novo mutation in DMD:
|
|
|
|
L: Pseudohypertrophy of the the calves
R: Lumbar Lordosis |
|
How do kids stand up in DMD?
|
-Gower's sign
-Due to proximal m weakness |
|
Becker Muscular Dystrophy
|
-X-linked
-Due to dystrophin mutation -Later onset (2-16 years) than DMD -Milder clinical course than DMD -Long survival (middle age) |
|
|
Becker Muscular Dystrophy
|
|
|
*DMD; you can see this with any muscular dystrophy
*Necrotic fibers with macrophages, fatty replacement of muscle, fibrosis, fiber size variability |
|
Role of dystrophin in muscle?
|
-Acts as a stabilizing bridge
|
|
|
|
|
Limb-Girdle Muscular Dystrophy
|
*A grouping of mutations
*Proximal muscle weakness *Autosomal dominant or recessive *Mutations in cytoskeletal proteins (e.g. sarcoglycans, caveolin) |
|
What kind of mutations do you see in Limb-Girdle Muscular Dystrophy?
|
A mutation in any of these!
|
|
Myotonic Muscular Dystrophy- Clinical Features:
|
*Onset at age 20-30
*DISTAL weakness *Myotonia—cannot relax contracted muscle *Hatchet-like face (atrophy of masseters) *Frontal baldness *Cataracts, cardiac conduction abnormalities, endocrine abnormalities *Progress is slow, sometimes spanning 50 to 60 years |
|
|
Myotonic dystrophy
|
|
Myotonic Muscular Dystrophy- Genetic traits:
|
*Autosomal dominant inheritance
*Chromosome 19q.13.3 – *Trinucleotide repeat (CTG) *Genetic anticipation *Codes for myosin protein kinase *Congenital form is always inherited from mother |
|
Myotonic Muscular Dystrophy-Pathologic Features:
|
Large numbers of central nuclei
Striated annulets (ring fibers) Selective atrophy of type I fibers |
|
|
-Myotonic Muscular Dystrophy
-Central nuclei and ring fiber *Large numbers of central nuclei *Striated annulets (ring fibers) *Selective atrophy of type I fibers |
|
Less common inherited myopathies:
|
*“Congenital” (e.g. central core disease +/- malignant hyperthermia)
*“Channelopathies” (ion channel myopathies) -Myotonia congenita -Periodic paralyses *Inborn errors of metabolism -Glycogen-storage myopathies -Lipid-storage myopathies *Mitochondrial myopathies |
|
Mitochondrial Myopathies:
|
*Muscle
*Extraocular muscles -Progressive external ophthalmoplegia -(Kearns-Sayre syndrome) *Brain -MELAS -MERRF |
|
traits of mito DNA:
|
-Has a different genetic code from nuclear DNA
-Is more tightly packed (no introns) -Mutates at a higher rate -Has less efficient repair mechanisms -Is present in hundreds of thousands of copies in every cell -Is maternally inherited |
|
|
A: Mitochondrial myopathy showing an irregular fiber with subsarcolemmal collections of mitochondria that stain red with the modified Gomori trichrome stain (ragged red fiber).
B: Electron micrograph of mitochondria from biopsy specimen in A showing "parking lot" inclusions (arrowheads). |
|
|
Ragged red fiber (trichrome stain)
-think MITOchondrial problem |
|
|
Paracrystalline (parking lot) inclusions in mitochondria (EM)
-think mitochondrial myopathy |
|
Acquired Myopathies:
|
*Toxic
-Intrinsic (e.g. thyrotoxic myopathy) -Extrinsic (e.g. alcohol, chloroquine, STATINS) *Inflammatory -Polymyositis -Dermatomyositis -Inclusion body myositis |
|
|
polymyositis
|
|
|
Dermatomyositis
|
|
Polymyositis vs. Dermatomyositis:
|
*Polymyositis (L)
CD8+ T-cells Direct fiber damage Inflammation around fibers Not antibody mediated *Dermatomyositis (R) B cells/CD4+ T-cells Ischemic fiber damage Inflammation around blood vessels Perifascicular atrophy Membrane-attack complex |
|
|
Invasion of intact fiber by lymphocytes- polymyositis
|
|
|
-Interstitial inflammation-polymyositis
-inflammatory cells completely surrounding the fiber |
|
|
Necrotic muscle fiber (myophagocytosis) in polymyositis (trichrome stain)
|
|
|
Skin rash- dermatomyositis
-don't ALWAYS see this |
|
|
Vascular inflammation-dermatomyositis
|
|
|
Focal muscle damage- dermatomyositis
|
|
|
Perifascicular Atrophy--Dermatomyositis
-due to decreased blood flow; an ischemic watershed phenomenon |
|
Inclusion Body Myositis:
|
*15-20% of inflammatory myopathies
*Patients older than 50 *M/F: 3/1 *Distal (upper limb), as well as proximal (lower) weakness *Myopathic and neurogenic features on EMG *CPK only mildly elevated *Lack of response to treatment |
|
Inclusion Body Myositis- Histologic Features:
|
*Modest inflammation
*Groups of atrophic fibers (correlation with neurogenic features on EMG) *Rimmed vacuoles!!! hallmark *Intranuclear virus-like particles on EM (difficult to find) *Inclusion bodies: staining for ubiquitin, amyloid, and amyloid precursor protein |
|
|
Rimmed vacuoles in Inclusion Body Myositis
|
|
|
Inclusion bodies stained for beta-amyloid in Inclusion Body Myositis
|
|
|
-Ultrastructure: Vacuoles contain tubulovesicular material
-EM correlate of inclusion bodies in Inclusion Body Myositis |
|
|
Filamentous intranuclear inclusion (low mag)
-in Inclusion Body Myositis |
|
|
Filamentous intranuclear inclusion (high mag) in Inclusion Body Myositis
|
|
Neuromuscular Junction disorders:
|
*Myasthenia gravis
Increasing weakness with repetitive action Antibodies to acetylcholine receptor May be associated with thymoma *Lambert-Eaton myasthenic syndrome Increasing strength with repetitive action Antibodies to presynaptic calcium channels Frequently a paraneoplastic (lung SCC) syndrome |
|
Rhabdomyosarcoma:
|
*Most common soft tissue sarcoma of childhood and adolescence
*Frequently in head/neck and GU regions *Associated with t(2;13) translocation: dysregulation of muscle differentiation by mutant protein |
|
|
Rhabdomyosarcoma: The rhabdomyoblasts are large and round and have abundant eosinophilic cytoplasm; no cross-striations are evident here.
|
|
Rhabdomyosarcoma- diagnosis, treatment, and prognosis:
|
*Diagnosis
Sarcomeres on electron microscopy Immunohistochemistry Muscle-specific actin DESMIN *Treatment: surgery, XRT, chemotherapy *Prognosis: potentially curable in 2/3 of children; adults do much worse |